Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Related studies linked through entity extraction aliases.